Summary
Background Inflammatory bowel disease is a global disease in the 21st century. We aimed to assess the changing Published Online
incidence and prevalence of inflammatory bowel disease around the world. October 16, 2017
http://dx.doi.org/10.1016/
S0140-6736(17)32448-0
Methods We searched MEDLINE and Embase up to and including Dec 31, 2016, to identify observational, population-
See Online/Comment
based studies reporting the incidence or prevalence of Crohn’s disease or ulcerative colitis from 1990 or later. A study http://dx.doi.org/10.1016/
was regarded as population-based if it involved all residents within a specific area and the patients were representative S0140-6736(17)32669-7
of that area. To be included in the systematic review, ulcerative colitis and Crohn’s disease needed to be reported *Contributed equally
separately. Studies that did not report original data and studies that reported only the incidence or prevalence of Department of Medicine and
paediatric-onset inflammatory bowel disease (diagnosis at age <16 years) were excluded. We created choropleth maps Therapeutics, Institute of
for the incidence (119 studies) and prevalence (69 studies) of Crohn’s disease and ulcerative colitis. We used temporal Digestive Disease, State Key
Laboratory of Digestive
trend analyses to report changes as an annual percentage change (APC) with 95% CI. Diseases, Li Ka Shing Institute
of Health Science, The Chinese
Findings We identified 147 studies that were eligible for final inclusion in the systematic review, including 119 studies of University of Hong Kong, Hong
incidence and 69 studies of prevalence. The highest reported prevalence values were in Europe (ulcerative colitis 505 per Kong Special Administrative
Region, China (Prof S C Ng PhD,
100 000 in Norway; Crohn’s disease 322 per 100 000 in Germany) and North America (ulcerative colitis 286 per 100 000 in H Y Shi PhD, W Tang MPhil,
the USA; Crohn’s disease 319 per 100 000 in Canada). The prevalence of inflammatory bowel disease exceeded 0·3% in Prof J C Y Wu MD,
North America, Oceania, and many countries in Europe. Overall, 16 (72·7%) of 22 studies on Crohn’s disease and Prof F K L Chan MD,
Prof J J Y Sung PhD);
15 (83·3%) of 18 studies on ulcerative colitis reported stable or decreasing incidence of inflammatory bowel disease in
Departments of Medicine and
North America and Europe. Since 1990, incidence has been rising in newly industrialised countries in Africa, Asia, and Community Health Sciences,
South America, including Brazil (APC for Crohn’s disease +11·1% [95% CI 4·8–17·8] and APC for ulcerative colitis University of Calgary, Calgary,
+14·9% [10·4–19·6]) and Taiwan (APC for Crohn’s disease +4·0% [1·0–7·1] and APC for ulcerative colitis +4·8% AB, Canada (N Hamidi MD,
F E Underwood MSc,
[1·8–8·0]).
Prof R Panaccione MD,
G G Kaplan MD); Children’s
Interpretation At the turn of the 21st century, inflammatory bowel disease has become a global disease with accelerating Hospital of Eastern Ontario
incidence in newly industrialised countries whose societies have become more westernised. Although incidence is Inflammatory Bowel Disease
Centre, Division of
stabilising in western countries, burden remains high as prevalence surpasses 0·3%. These data highlight the need for
Gastroenterology, Hepatology
research into prevention of inflammatory bowel disease and innovations in health-care systems to manage this complex and Nutrition, Children’s
and costly disease. Hospital of Eastern Ontario,
Ottawa, ON, Canada
(E I Benchimol MD);
Funding None.
Department of Pediatrics and
School of Epidemiology, Public
Introduction 21st century.4 Although the incidence of ulcerative colitis Health and Preventive
The inflammatory bowel diseases, Crohn’s disease and and Crohn’s disease increased in the western world in the Medicine, University of
Ottawa, Ottawa, ON, Canada
ulcerative colitis, are chronic idiopathic disorders causing latter half of the 20th century,4,5 little was known about the (E I Benchimol); Institute for
inflammation of the gastro-intestinal tract.1 In the past changing incidence in other parts of the world. Now, Clinical Evaluative Sciences,
decade, inflammatory bowel disease has emerged as a newer epidemiological studies suggest that incidence Toronto, ON, Canada
public health challenge worldwide.2 In North America might be rising rapidly in South America, eastern Europe, (E I Benchimol); NIHR
Biomedical Research Centre,
and Europe, over 1·5 million and 2 million people suffer Asia, and Africa. Additionally, an increase in disease Institute of Translational
from the disease, respectively.3 Outside the western world incidence among ethnicities and nationalities in whom Medicine, University of
(ie, countries influenced by a western European cultural inflammatory bowel diseases were previously uncommon Birmingham, Birmingham, UK
heritage, including the USA, Canada, Australia, New has substantial implications for the understanding of (Prof S Ghosh MD); and
Department of
Zealand, and all countries in western Europe), the pathogenesis and environmental triggers in differing Gastroenterology, Beijing
number of individuals affected by inflammatory bowel populations.6 This epidemiological shift, which is being Friendship Hospital, Capital
disease remains unclear.4 seen in newly industrialised countries and in Asian Medical University, National
Traditionally regarded as a disease of westernised immigrants to the west, mirrors the experience reported Clinical Research Center for
Digestive Disease, Beijing,
nations, the epidemiology of inflammatory bowel disease in the west more than 50 years ago, occurring with rapid China (H Y Shi)
is changing throughout the world at the turn of the socioeconomic development.7
Correspondence to:
Dr Gilaad Kaplan, Departments Research in context
of Medicine and Community
Health Sciences, University of Evidence before this study North America, Oceania, and most countries in Europe. By
Calgary, Calgary, AB T2N 4Z6, In a previous systematic review, we searched MEDLINE from contrast, newly industrialised countries in Africa, Asia, and
Canada
1950 to 2010 (8103 citations) and Embase from 1980 to 2010 South America whose societies become increasingly
ggkaplan@ucalgary.ca
(4975 citations) for population-based studies that reported the westernised and urbanised, are mirroring the progression of
or
Prof Siew C Ng, Department of incidence or prevalence of Crohn’s disease or ulcerative colitis. inflammatory bowel disease in the western world during
Medicine and Therapeutics, The search identified 260 population-based studies on the the 1900s.
Institute of Digestive Disease, incidence or prevalence of Crohn’s disease or ulcerative colitis.
State Key Laboratory of Digestive Implications of all the available evidence
Collectively, these studies defined the epidemiological patterns
Diseases, Li Ka Shing Institute of Since the recognition of ulcerative colitis in 1875 and Crohn’s
Health Science, The Chinese of the inflammatory bowel diseases during the 20th century.
disease in 1932, the incidence of inflammatory bowel disease
University of Hong Kong, Hong Since the 1950s, the incidence and prevalence of inflammatory
has increased substantially in the western world. Our findings
Kong Special Administrative bowel disease steadily increased in the countries of
Region, China show a paradigm shift whereby the incidence of inflammatory
North America, Europe, and Australia. During this time, more
siewchienng@cuhk.edu.hk bowel disease in most western countries has begun to stabilise
than two-thirds of studies reported that incidence rates were
and in some regions decrease. However, after several decades
increasing significantly in the western world. We define the
of sharply rising incidence, the prevalence of inflammatory
western world as consisting of countries influenced by a
bowel disease has risen to more than 0·3% of the population in
western European cultural heritage, including the USA, Canada,
North America, Australia, and many countries in Europe. The
Australia, New Zealand, and all countries in western Europe. By
high prevalence of inflammatory bowel disease in the western
contrast, few population-based studies on the epidemiology of
world will challenge clinicians and health policy makers to
inflammatory bowel disease were published from countries in
provide quality and cost-efficient care to patients with
Africa, Asia, and South America. At the turn of the 21st century,
inflammatory bowel disease. More striking is the observation
additional epidemiological studies have been reported from
that as newly industrialised countries have transitioned
across the world. For example, the Asia-Pacific Crohn’s and
towards a westernised society, inflammatory bowel disease
Colitis Epidemiologic Study Group (ACCESS) defined the
emerges and its incidence rises rapidly. The peak in the
incidence of inflammatory bowel disease in 12 countries in Asia
incidence of inflammatory bowel disease has probably not yet
and Australia. These newer studies, which were not included in
transpired in these newly industrialised countries.
the original systematic review, have shed light on the changing
Consequently, these countries will need to prepare their clinical
global epidemiological patterns of inflammatory bowel disease.
infrastructure and personnel to manage this complex and
Added value of this study costly disease. During the past 100 years, the incidence of
We did a systematic review of population-based studies on the inflammatory bowel disease has risen, then plateaued in the
incidence (119 studies) or prevalence (69 studies) of western world, whereas countries outside the western world
inflammatory bowel disease from 1990 to 2016. Since 1990, seem to be in the first stage of this sequence. Thus, future
incidence rates have shifted in western countries, with 73% of research should focus on identification of the environmental
studies on Crohn’s disease and 83% of studies on ulcerative risk factors seen during the early stages of industrialisation of
colitis showing stable or falling incidence. However, disease society to highlight avenues to prevent the development of
burden remains high, with prevalence surpassing 0·3% in inflammatory bowel disease.
In the western world, inflammatory bowel disease is geographical regions and did temporal trend analyses of
associated with morbidity, mortality, and substantial costs incidence. We aimed to update the information provided
to the health-care system.3,8 The rising incidence of by our previous report,5 and provide insight into the
inflammatory bowel disease in newly industrialised epidemiology of inflammatory bowel disease from a
countries could indicate an emerging epidemic of the global perspective.
disease outside the western world. This observation
suggests that the impact of inflammatory bowel disease Methods
on health-care systems will need to be reassessed in the Search strategy and selection criteria
context of shifting epidemiological patterns throughout For this systematic review, we first identified studies
the world. Furthermore, insight into geographical reporting the incidence and prevalence of inflammatory
patterns and disease time trends will help researchers bowel disease from 1990 onwards from our previous
and policy makers to prepare the clinical infrastructure systematic review.5 We updated the previous database
and health-care resources needed to mitigate the burden search by searching MEDLINE and Embase from
of inflammatory bowel disease. Dec 1, 2010, to Dec 31, 2016, to identify population-based
We did a systematic review of population-based studies studies reporting the incidence and prevalence of
reporting the incidence of inflammatory bowel disease inflammatory bowel disease. We did the search using a
across the world since 1990 based on different pre-determined search strategy and in accordance with
Western Europe
.. revalence
Ulcerative cOhtl~~_2016
per 100 000, 19
D Unknown
• 2-42-21 ·00
D 21·10-44·30
D 44-40-100'90
D 101 ·00 -198·00
D >198·00
Western Europe
*Geelong has the lowest and highest estimates because of reporting in time periods ranging from 2007 to 2013.
Table: Range in incidence and prevalence of inflammatory bowel disease since 1990 stratified by geographic regions
from Europe have shown a north–south gradient of disease quality, reporting, and completeness between databases
incidence,31,32 whereas in Canada, a nationwide comparison could have contributed to the differences seen between
showed an east–west disease gradient.33 The ACCESS countries. Additionally, study quality was not an exclusion
cohort found a north–south gradient across all regions in criterion and therefore probably contributed to differences
Asia for inflammatory bowel disease and ulcerative colitis, in incidence and prevalence estimates. Some studies
but not for Crohn’s disease (unpublished).28 Additionally, a reported crude incidence rates, whereas others reported
south–north gradient and west–east gradient for the age-adjusted or sex-adjusted incidence rates. Because of
incidence of Crohn’s disease was seen in China, with the different study periods and reporting of annual
higher incidences in southern and western parts of China. incidence, temporal trends were not homogeneous
Collectively, historical and epidemiological data from between studies.
the past century and a half suggest that the emergence of This systematic review provides a comprehensive global
inflammatory bowel disease has followed the industrial overview of the incidence and prevalence of inflammatory
isation and westernisation of society.4 Sir Walter Wilks bowel disease over the past generation. We have identified
originally coined the term ulcerative colitis in 1875,34 and a substantial shift in the epidemiology of inflammatory
the landmark paper on Crohn’s disease by Burrill bowel disease. Since 1990, the incidence of inflammatory
Bernard Crohn, Leon Ginzburg, and Gordon bowel disease has stabilised in the western world, but
Oppenheimer was published in 1932.7,35 During the prevalence remains high. By contrast, newly industrialised
20th century, the incidence of both ulcerative colitis and countries are facing rising incidence, analogous to trends
Crohn’s disease increased substantially in the western seen in the western world during the latter part of the
world with earlier studies showing that the incidence of 20th century. Unfortunately, the peak in the incidence of
ulcerative colitis was higher than that of Crohn’s disease.5 inflammatory bowel disease has probably not yet
Later, epidemiological studies showed that the incidence transpired in these countries. The changing global
of Crohn’s disease was catching up, and in many regions burden of inflammatory bowel disease during the next
in the western world, surpassing that of ulcerative colitis.5 decade will require a two-pronged solution that involves
Analogous epi demiological patterns have also been research into interventions to prevent inflammatory
reported in newly industrialised countries outside the bowel disease and innovations in the delivery of care to
western world—just shifted forward in time. For patients with inflammatory bowel disease.
example, the earliest case reports in China of ulcerative Contributors
colitis were in the 1950s, with the early epidemiological SCN, HYS, NH, FEU, WT, EIB, RP, SG, JCYW, FKLC, JJYS, and GGK
studies mostly describing ulcerative colitis.7 Although contributed to the study design. SCN, HYS, NH, FEU, WT, and GGK did
the data collection and the literature search. FEU created the figures.
ulcerative colitis is still more common in Asia than Data were analysed by SCN and GGK and interpreted by SCN, HYS,
Crohn’s disease, data from more recent epidemiological NH, FEU, WT, EIB, RP, SG, JCYW, FKLC, JJYS, and GGK. The
studies have shown that the incidence of Crohn’s disease manuscript was written by SCN, HYS, NH, FEU, WT, EIB, RP, SG,
is catching up.7 Future studies are needed to establish JCYW, FKLC, JJYS, and GGK. All authors saw and approved the
manuscript. SCN and GGK had full access to all of the data in the study
whether the rising incidence rates in newly industrialised and take responsibility for the integrity of the data and the accuracy of
countries approximate those of the western world during the data analysis.
the 20th century. If so, the prevalence of inflammatory Declaration of interests
bowel disease is likely to steadily increase in newly We declare no competing interests.
industrialised countries. Acknowledgments
Our study has some limitations. We did a compre EIB was supported by a New Investigator Award from the Canadian
hensive systematic review of the published literature on Institutes for Health Research, Canadian Association of Gastroenterology,
the incidence and prevalence of inflammatory bowel and Crohn’s and Colitis Canada. EIB was also supported by the Career
Enhancement Program of the Canadian Child Health Clinician Scientist
disease, but we chose not to do a meta-analysis because of Program. GGK is a Canadian Institutes for Health Research-Embedded
variability between studies.5 We stratified regions by Clinician Research Chair.
geography on the basis of proximity of countries within a References
continent, recognising that many differences exist 1 Baumgart DC, Carding SR. Inflammatory bowel disease: cause and
between countries within a geographical zone that could immunobiology. Lancet 2007; 369: 1627−40.
2 Kaplan GG. The global burden of IBD: from 2015 to 2025.
lead to variability in reporting of the incidence and Nat Rev Gastroenterol Hepatol 2015; 12: 720−27.
prevalence of inflammatory bowel disease. Heterogeneity 3 Burisch J, Jess T, Martinato M, Lakatos PL, for ECCO EpiCom.
between countries could be explained by differences in The burden of inflammatory bowel disease in Europe. J Crohns Colitis
2013; 7: 322−37.
genetic predisposition, environmental exposures, socio 4 Kaplan GG, Ng SC. Understanding and preventing the global
economic factors, and immi gration.4 Heterogeneity increase of inflammatory bowel disease. Gastroenterology 2017;
between studies could also be explained by methodological 152: 313−21.
5 Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and
limitations, some of which include differences in pop prevalence of the inflammatory bowel diseases with time, based on
ulation characteristics, study designs, access to health systematic review. Gastroenterology 2012; 142: 46−54.
care, and the advancement of diagnostic approaches 6 Frolkis A, Dieleman LA, Barkema H, et al. Environment and the
inflammatory bowel diseases. Can J Gastroenterol 2013; 27: e18−24.
between countries.36 Furthermore, differences in data
7 Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: 22 Kurti Z, Vegh Z, Golovics PA, et al. Nationwide prevalence and
perspectives from the evolution of inflammatory bowel disease in the drug treatment practices of inflammatory bowel diseases in
UK and China. Lancet Gastroenterol Hepatol 2016; 1: 307−16. Hungary: a population-based study based on the National
8 Rocchi A, Benchimol EI, Bernstein CN, et al. Inflammatory bowel Health Insurance Fund database. Dig Liver Dis 2016; 48: 1302−07.
disease: a Canadian burden of illness review. Can J Gastroenterol 2012; 23 Busch K, Ludvigsson JF, Ekstrom-Smedby K, Ekbom A, Askling J,
26: 811−17. Neovius M. Nationwide prevalence of inflammatory bowel disease
9 Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of in Sweden: a population-based register study.
observational studies in epidemiology: a proposal for reporting. Aliment Pharmacol Ther 2014; 39: 57−68.
JAMA 2000; 283: 2008−12. 24 Stone MA, Mayberry JF, Baker R. Prevalence and management of
10 United Nations. Standard country or area codes for statistical use inflammatory bowel disease: a cross-sectional study from central
(M49). https://unstats.un.org/unsd/methodology/m49/ (accessed England. Eur J Gastroenterol Hepatol 2003; 15: 1275−80.
June 1, 2017). 25 Gearry RB, Richardson A, Frampton CM, et al. High incidence of
11 Natural Earth Development Team. 1:10m cultural vectors. Crohn’s disease in Canterbury, New Zealand: results of an
North American Cartographic Information Society. epidemiologic study. Inflamm Bowel Dis 2006; 12: 936−43.
http://www.naturalearthdata.com/downloads/10m-cultural-vectors/ 26 Studd C, Cameron G, Beswick L, et al. Never underestimate
(accessed June 1, 2017). inflammatory bowel disease: high prevalence rates and
12 Klarin I, Majnaric L, Jovanovic Z, Nakic D, Vcev I, Vcev A. confirmation of high incidence rates in Australia.
Epidemiology and clinical presentation of inflammatory bowel J Gastroenterol Hepatol 2016; 31: 81−86.
disease in Zadar County, Croatia. Coll Antropol 2013; 37: 1161−70. 27 Coward S, Clement F, Williamson T, et al. The rising burden of
13 Salkic NN, Pavlovic-Calic N, Gegic A, Jovanovic P, Basic M. inflammatory bowel disease in North America from 2015 to 2025:
Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina a predictive model. Am J Gastroenterol 2015; 110 (suppl 1): abstr 1959.
between 1995 and 2006: epidemiological and clinical characteristics. 28 Ng S, Kaplan GG, Tang W, et al. Incidence and phenotype of
Eur J Gastroenterol Hepatol 2010; 22: 346−53. inflammatory bowel disease from 13 countries in Asia-Pacific:
14 Services US Department of Health and Human Services. The health results from the Asia-Pacific Crohn’s and Colitis epidemiologic
consequences of smoking—50 years of progress. Rockville, MD: study 2011−2013. Gastroenterol 2016; 150 (suppl 1): S21.
National Library of Medicine, 2014. 29 Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of
15 Benchimol EI, Manuel DG, Guttmann A, et al. Changing age inflammatory bowel disease in Korea, 2006−2012: a nationwide
demographics of inflammatory bowel disease in Ontario, Canada: population-based study. Inflamm Bowel Dis 2015; 21: 623−30.
a population-based cohort study of epidemiology trends. 30 Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory
Inflamm Bowel Dis 2014; 20: 1761−69. bowel disease in the Songpa-Kangdong district, Seoul, Korea,
16 Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, 1986−2005: a KASID study. Inflamm Bowel Dis 2008; 14: 542−49.
Van Limbergen J, Griffiths AM. Epidemiology of pediatric 31 Nerich V, Monnet E, Etienne A, et al. Geographical variations of
inflammatory bowel disease: a systematic review of international inflammatory bowel disease in France: a study based on national
trends. Inflamm Bowel Dis 2011; 17: 423−39. health insurance data. Inflamm Bowel Dis 2006; 12: 218−26.
17 Benchimol EI, Mack DR, Guttmann A, et al. Inflammatory bowel 32 Nerich V, Monnet E, Weill A, et al. Fine-scale geographic variations of
disease in immigrants to Canada and their children: inflammatory bowel disease in France: correlation with socioeconomic
a population-based cohort study. Am J Gastroenterol 2015; 110: 553−63. and house equipment variables. Inflamm Bowel Dis 2010; 16: 813−21.
18 Benchimol EI, Manuel DG, To T, et al. Asthma, type 1 and type 2 33 Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of
diabetes mellitus, and inflammatory bowel disease amongst inflammatory bowel disease in Canada: a population-based study.
South Asian immigrants to Canada and their children: Am J Gastroenterol 2006; 101: 1559−68.
a population-based cohort study. PLoS One 2015; 10: e0123599. 34 Wilks S, Moxon W. Lectures on pathological anatomy, 2nd edn.
19 Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV. London: J&A Churchill, 1875.
Incidence and prevalence of Crohn’s disease and ulcerative colitis 35 Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis:
in Olmsted County, Minnesota from 1970 through 2010. a pathologic and clinical entity. JAMA 1932; 99: 1323–29.
Clin Gastroenterol Hepatol 2017; 15: 857–63. 36 Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG.
20 Jacobsen BA, Fallingborg J, Rasmussen HH, et al. Increase in Challenges associated with identifying the environmental
incidence and prevalence of inflammatory bowel disease in determinants of the inflammatory bowel diseases. Inflamm Bowel Dis
northern Denmark: a population-based study, 1978−2002. 2011; 17: 1792−99.
Eur J Gastroenterol Hepatol 2006; 18: 601−06.
21 Hein R, Koster I, Bollschweiler E, Schubert I. Prevalence of
inflammatory bowel disease: estimates for 2010 and trends in
Germany from a large insurance-based regional cohort.
Scand J Gastroenterol 2014; 49: 1325−35.